Contrastingly, other studies show that anti-TNF-α medication is effective and successful for connective tissue disease (CTD) [60], particularly SLE and cutaneous lupus erythematosus (CLE) [20]. The gene discussed is TNF; the disease is systemic lupus erythematosus.